Literature DB >> 30877180

Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.

Suzanne L Baker1, Theresa M Harrison2, Anne Maass2,3, Renaud La Joie4, William J Jagust5,2.   

Abstract

Measuring early tau accumulation is important in studying aging and Alzheimer disease and is only as accurate as the signal-to-noise ratio of the tracer. Along with aggregated tau in the form of neurofibrillary tangles, 18F-flortaucipir has been reported to bind to neuromelanin, monoamine oxidase, calcifications, iron, leptomeningeal melanocytes, and microhemorrages. Although 18F-flortaucipir successfully differentiates healthy controls (HCs) from subjects with Alzheimer disease, variability exists in the cortical signal in amyloid-negative HCs. We aimed to explore the relationship between off-target binding signal and variability in the cortical signal in HCs.
Methods: Subjects (n = 139) received 11C-Pittsburgh compound B (PIB) and 18F-flortaucipir PET scans and a magnetization-prepared rapid gradient echo MRI scan. PET frames were realigned and coregistered to the MR images, which were segmented using FreeSurfer. In amyloid-negative HCs (n = 90; age range, 21-94 y), 7 nonspecific or off-target binding regions were considered: caudate, pallidum, putamen, thalamus, cerebellar white matter, hemispheric white matter, and choroid plexus. These regions of interest were assigned to 3 similarly behaving groups using principle components analysis, exploratory factor analysis, and Pearson correlations for caudate, putamen, and pallidum (also correlated with age); thalamus and white matter; and choroid plexus. In amyloid-negative HCs with 11C-PIB and 18F-flortaucipir scans, correlations were calculated between white and gray matter before and after partial-volume correction.
Results: The correlation between white and gray matter disappeared after partial-volume correction in 11C-PIB (r 2 = 0) but persisted for 18F-flortaucipir (r 2 = 0.27), demonstrating that the correlation between white and gray matter signal in 18F-flortaucipir is not solely due to partial-volume effects. A linear regression showed that off-target signal from putamen and thalamus together explained 64% of the variability in the cortical signal in amyloid-negative HCs (not seen in amyloid-positive HCs). Variability in amyloid-negative HCs but not amyloid-positive HCs correlated with white matter signal (unrelated to partial-volume effects) and age-related off-target signal (possibly related to iron load).
Conclusion: The noise in the 18F-flortaucipir measurement could pose challenges when studying early tau accumulation.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-flortaucipir PET; off-target binding; tau

Year:  2019        PMID: 30877180      PMCID: PMC6785795          DOI: 10.2967/jnumed.118.224113

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  35 in total

1.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors:  David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

3.  Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Authors:  Val J Lowe; Heather J Wiste; Matthew L Senjem; Stephen D Weigand; Terry M Therneau; Bradley F Boeve; Keith A Josephs; Ping Fang; Mukesh K Pandey; Melissa E Murray; Kejal Kantarci; David T Jones; Prashanthi Vemuri; Jonathan Graff-Radford; Christopher G Schwarz; Mary M Machulda; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

4.  Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease.

Authors:  Sergey Shcherbinin; Adam J Schwarz; Abhinay Joshi; Michael Navitsky; Matthew Flitter; William R Shankle; Michael D Devous; Mark A Mintun
Journal:  J Nucl Med       Date:  2016-05-05       Impact factor: 10.057

5.  Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects.

Authors:  Olivier Barret; David Alagille; Sandra Sanabria; Robert A Comley; Robby M Weimer; Edilio Borroni; Mark Mintun; Nicholas Seneca; Caroline Papin; Thomas Morley; Ken Marek; John P Seibyl; Gilles D Tamagnan; Danna Jennings
Journal:  J Nucl Med       Date:  2016-12-01       Impact factor: 10.057

6.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Authors:  Rik Ossenkoppele; Gil D Rabinovici; Ruben Smith; Hanna Cho; Michael Schöll; Olof Strandberg; Sebastian Palmqvist; Niklas Mattsson; Shorena Janelidze; Alexander Santillo; Tomas Ohlsson; Jonas Jögi; Richard Tsai; Renaud La Joie; Joel Kramer; Adam L Boxer; Maria L Gorno-Tempini; Bruce L Miller; Jae Y Choi; Young H Ryu; Chul H Lyoo; Oskar Hansson
Journal:  JAMA       Date:  2018-09-18       Impact factor: 56.272

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.

Authors:  Christopher M Lee; Heidi I L Jacobs; Marta Marquié; John A Becker; Nicolas V Andrea; David S Jin; Aaron P Schultz; Matthew P Frosch; Teresa Gómez-Isla; Reisa A Sperling; Keith A Johnson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.

Authors:  Sylvia Villeneuve; Gil D Rabinovici; Brendan I Cohn-Sheehy; Cindee Madison; Nagehan Ayakta; Pia M Ghosh; Renaud La Joie; Samia Kate Arthur-Bentil; Jacob W Vogel; Shawn M Marks; Manja Lehmann; Howard J Rosen; Bruce Reed; John Olichney; Adam L Boxer; Bruce L Miller; Ewa Borys; Lee-Way Jin; Eric J Huang; Lea T Grinberg; Charles DeCarli; William W Seeley; William Jagust
Journal:  Brain       Date:  2015-05-06       Impact factor: 13.501

10.  Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data.

Authors:  Suzanne L Baker; Anne Maass; William J Jagust
Journal:  Data Brief       Date:  2017-10-16
View more
  33 in total

Review 1.  A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy.

Authors:  Cyrus Ayubcha; Mona-Elisabeth Revheim; Andrew Newberg; Mateen Moghbel; Chaitanya Rojulpote; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-21       Impact factor: 9.236

2.  The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults.

Authors:  Sepideh Shokouhi; Alexander C Conley; Suzanne L Baker; Kimberly Albert; Hakmook Kang; Harry E Gwirtsman; Paul A Newhouse
Journal:  Neurobiol Aging       Date:  2019-05-23       Impact factor: 4.673

3.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

Review 4.  Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.

Authors:  Rachel F Buckley
Journal:  Neurotherapeutics       Date:  2021-03-29       Impact factor: 7.620

5.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

6.  Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy.

Authors:  William G Mantyh; Salvatore Spina; Alex Lee; Leonardo Iaccarino; David Soleimani-Meigooni; Elena Tsoy; Taylor J Mellinger; Harli Grant; Lawren Vandevrede; Renaud La Joie; Orit Lesman-Segev; Stephanie Gaus; Katherine L Possin; Lea T Grinberg; Bruce L Miller; William W Seeley; Gil D Rabinovici
Journal:  JAMA Neurol       Date:  2020-04-01       Impact factor: 18.302

7.  18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.

Authors:  David N Soleimani-Meigooni; Leonardo Iaccarino; Renaud La Joie; Suzanne Baker; Viktoriya Bourakova; Adam L Boxer; Lauren Edwards; Rana Eser; Maria-Luisa Gorno-Tempini; William J Jagust; Mustafa Janabi; Joel H Kramer; Orit H Lesman-Segev; Taylor Mellinger; Bruce L Miller; Julie Pham; Howard J Rosen; Salvatore Spina; William W Seeley; Amelia Strom; Lea T Grinberg; Gil D Rabinovici
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

8.  Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults.

Authors:  Daniel S Albrecht; Abhay Sagare; Maricarmen Pachicano; Melanie D Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; John C Morris; Tammie Benzinger; Judy Pa
Journal:  Brain Behav Immun       Date:  2021-01-22       Impact factor: 7.217

Review 9.  Molecular Imaging Approaches in Dementia.

Authors:  Victor L Villemagne; Frederik Barkhof; Valentina Garibotto; Susan M Landau; Agneta Nordberg; Bart N M van Berckel
Journal:  Radiology       Date:  2021-01-19       Impact factor: 11.105

Review 10.  Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases.

Authors:  Christopher G Schwarz
Journal:  Neurotherapeutics       Date:  2021-03-15       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.